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IntRoductIon
Thyroid hormones and renal functions have a multifaceted mutual interdependence. Thyroid hormones exert influence on water and electrolyte milieu in our body. Renal growth involves thyroid hormones making their contribution to renal physiology important. [1] Decrease in iodothyronines is associated with reduced blood flow to kidneys and decreased glomerular filtration rate (GFR) along with alteration in tubular reabsorption resulting in decrease in water excretion. [2] Conversely, thyrotoxicosis is found to cause polyuria following enhanced glomerular filtration and tubular reabsorption. [3] At the same time, kidneys not only contribute significantly to metabolism and removal of thyroid hormones from the body but also play important role in certain actions of these hormones. [1, 4] Therefore, the decline of kidney function is accompanied by changes in thyroid hormone levels.
The prevalence of subclinical hypothyroidism increases consistently with decline in GFR. [5] Renal disease, both acute and chronic, has been found to be associated with significant effects on the hypothalamus-pituitary-thyroid axis. Thyroid-stimulating hormone (TSH) levels may be normal or increased in chronic kidney disease (CKD) but with reduced response to thyrotropin releasing hormone (TRH). There is alteration in circadian rhythm and activity, suggesting abnormality at the level of hypophyses.
Major fraction of thyroxine hormones exist in protein-bound state in blood which may be affected in CKD. Patients with CKD have inhibitors which prevent binding of thyroid hormones to proteins. [6] Another aspect looking into the role of inflammation affecting the thyroid functions in patients with CKD is also generating interest recently. Hence, an important interplay between thyroid hormone status and kidney function highlights the significance of understanding the correlation between them.
Our study assessed thyroid hormone status in undialyzed CKD patients, comparing them with control group, to find the correlation between biochemical markers of renal function and thyroid hormone levels.
Methodology
We conducted a hospital-based case-control observational study in a tertiary care center in Northwestern part of India. After obtaining informed consent, thirty patients of age more than 14 years having established CKD and not on dialysis were included as cases. A similar number of age-and sex-matched healthy controls were taken as controls. Patients with known history of thyroid disorder, on drugs affecting thyroid function, pregnancy, and previous history of dialysis were excluded from the study. Ethical committee clearance was obtained before the study.
A thorough history was taken from the individuals enrolled in the study population. Blood sample taken after overnight fasting was analyzed for complete blood counts, blood glucose, blood urea, serum creatinine, serum calcium and phosphorus, liver function tests, serum proteins, serum electrolytes, complete urine analysis, and thyroid hormone levels (TSH, free triiodothyronine [FT3], free thyroxine [FT4]).
Biochemical parameters were analyzed in biochemistry laboratory, and thyroid hormones were estimated using chemiluminescent immunoassay system in Immulite 1000 Siemens machine in the immunoassay laboratory of the institute. Ultrasonography (USG) abdomen was done for evaluation of kidney size and corticomedullary differentiation.
Same number of age-and sex-matched healthy controls were evaluated for all above-mentioned investigations. Data were collected and statistically analyzed. GFR was calculated by Modification of Diet in Renal Disease Study formula.
Statistical analysis
All the data obtained were presented as mean ± standard deviation. Any differences in parameters between groups were tested for significance by two-tailed unpaired t-test. Comparisons were made between controls and cases groups. P = <0.05 was considered to be statistically significant. Pearson's correlation analysis was done to study any correlations between renal biochemistry and thyroid levels. All the statistical analyses were performed on SPSS for Microsoft Windows trial version 23 (SPSS inc., Chicago, Il,USA).
Results
The age and sex distribution in both the groups were comparable, and difference between groups was statistically insignificant. It was also observed that male patients were disproportionately larger in number (56.6%) as compared to females (43.3%).
Results in cases and control groups were as tabulated in Table 1 . Mean FT3 was lesser in cases (1.4727 ± 0.3577) than controls (2.6613 ± 0.6155); the difference being statistically significant. Mean FT4 of cases was 0.9013 ± 0.1916, and in controls, it was 1.4263 ± 0.2594, there being less mean serum FT4 in cases as compared to controls and the difference between both the groups being significant. Mean serum TSH in cases was 1.8120 ± 1.0844, and in controls, it was 2.5233 ± 0.7447. There was higher mean serum TSH in controls as compared to cases, and the difference among both the groups was significant.
As the cases group consisted of undialyzed CKD patients, mean blood urea and mean serum creatinine of cases were significantly higher than those in controls. There was higher mean creatinine clearance in controls as compared to cases, and the difference among both the groups was significant. On USG, out of total cases, 63.33% had bilateral contracted kidneys and 36.67% had poor corticomedullary differentiation. All controls had normal USG findings.
Distribution of cases and controls according to FT3 range revealed that the levels of FT3 were significantly abnormal in 76.64% of the cases as compared to none in the controls. We also found significantly abnormal levels of FT4 in 70% of undialyzed CKD patients as compared to 13.34% of healthy controls, with mean FT4 in cases group being lower to control group, the difference being statistically significant (χ 2 = 17.554 with 1° of freedom; P = <0.001).
TSH was found abnormal in 26.66% of the cases as compared to 6.67% in the controls (χ 2 = 3.0000 with 1° of freedom; P = 0.083). Abnormal TSH values were not statistically significant in both groups.
Correlation between thyroid hormone profile and markers of renal function
There was moderate-to-strong inverse correlation between the blood urea and FT3 (r = −0.749, P < 0.01, R 2 = 0.56) as well as between the creatinine and serum FT3 (r = −0.692, P < 0.01, R 2 = 0.479). Significant moderately strong correlation was seen between creatinine clearance and FT3 (r = 0.686, P < 0.01, R2 = 0.47) [ Figure 1 ]. Correlation of FT4 with renal parameters also showed significant inverse moderately strong correlation between the blood urea values and serum FT4 (r = −0.723, P < 0.01, R 2 = 0.52) as well as serum creatinine and FT4 (r = −0.684, P < 0.01, R 2 = 0.459). Significant moderately strong correlation was observed between the creatinine clearance values and FT4 (r=0.699, P <0.01) using Pearson's correlation coefficient [ Figure 2 ]. The R 2 = 0.49, it means 49% of the total variation in serum FT4 was explained by the linear relation with creatinine clearance.
No significant correlation was seen between the blood urea values and serum TSH (r = 0.236, P = 0.069) using Pearson's correlation coefficient. The R 2 = 0.056, it means 5.6% of the total variation in serum TSH was explained by the linear relation with blood urea. There was just significant positive correlation between the serum creatinine values and serum TSH (r = 0.248, P = 0.049, R 2 = 0.061). Nonsignificant correlation between the creatinine clearance values and serum TSH was observed (r = 0.206, P = 0.114, R2 = 0.42) [ Figure 3 ].
Summarizing the results, there was significant inverse moderately strong correlation between the blood urea and free thyroid hormones as well as between serum creatinine and free thyroid hormones. There was no significant positive correlation between the blood urea values and TSH, with just significant positive correlation between the serum creatinine and TSH. We observed significant moderately strong correlation between the creatinine clearance values and FT3 and FT4 with no significant correlation with TSH.
dIscussIon
Many alterations in thyroid functions have been reported in association with CKD patients. We conducted a case-control observational study to correlate thyroid hormones status in undialyzed CKD patients and healthy controls. In our study, patients only on conservative management were studied. This is because thyroid profile undergoes changes due to dialysis independent of that due to CKD. Dialysis also changes the previous serum status of thyroid hormone in the patients with renal failure.
The levels of FT3 and FT4 in our study were significantly abnormal (lower) in undialyzed CKD patients as compared to healthy controls. Free thyroid hormone levels significantly decreased with rising blood urea, serum creatinine, and declining creatinine clearance. Nonsignificant correlation occurred between the blood urea values and creatinine clearance with TSH. There was just significant positive correlation between the serum creatinine values and TSH.
Various patterns of alteration of thyroid profile in CKD patients have been reported in literature. Singh et al. evaluated thyroid hormones status and oxidative stress in 20 undialyzed CKD patients and 20 controls. They observed a significant decrease in the levels of T3, T4, total protein, and albumin levels in patients with kidney disease as compared to control. [7] A study was conducted by Haria and Lunia in 2013 to evaluate the thyroid hormones status in patients with CKD. They observed decreased total thyroid hormone and FT3 levels in 74% CKD patients whereas TSH, FT4 were similar to controls. [8] Mehta et al. in 1991 conducted a study to evaluate total and free thyroid hormone levels in chronic renal failure. They found that significant decrease in TT3, FT4, and FT3 levels was associated with increasing renal damage.
[9] Rajagopalan et al. in 2013 found significant reduction in T3 and T4 with unchanged TSH in patients with CKD as compared to controls. They also found a significant negative correlation of blood urea and serum creatinine with thyroid hormones.
[10] In a study from Nepal, the authors found abnormal thyroid function in patients with CKD. They found subclinical hypothyroidism to be significantly associated with CKD and also association of CKD progression to thyroid function abnormalities. [11] In a pioneering study, Ramirez et al. compared two groups of patients with renal failure not on dialysis and those on dialysis with normal individuals. They observed significantly reduced T3 in both renal failure groups when compared to normal individuals. However, the reduction in T4 was statistically significant only in hemodialysis group. [12] These findings were not associated with decrease in thyroid binding globulin in nonhemodialysis renal failure group suggesting pathophysiology independent of binding proteins.
Our study found no significant alterations in mean TSH level in CKD patients as compared to controls. The mean TSH levels were comparable to controls for the various ranges of GFR. TSH levels did not show any correlation with the severity of renal failure. This is consistent with the results obtained by Ramirez et al. [12] and Lim. [6] Ramirez et al. observed impaired response of thyrotropin to its releasing hormone indicating abnormality in hypothalamic-pituitary axis in patients with CKD. The uremic patients had probably a defective pituitary response highlighting the role of pituitary in contributing to ineffective negative feedback mechanism. [12] However, contrary to this, Joseph et al. demonstrated high TSH in the presence of low thyroid hormones. They observed thyrotropin levels rising with degree of renal insufficiency, favoring a normal thyroid hypophyseal feedback loop.
[13] Serum TSH glycosylation may be affected along with reduced response to its releasing hormone, TRH. [14] Furthermore, reduced thyroid hormone response to TSH has been demonstrated low. [7, 12] Role of inflammation has been studied in disorders such as malnutrition, sepsis, chronic renal disorders, and myocardial infarction producing condition of stress and leading to thyroid disturbances. [15] Effect of cytokines and interleukins has been considered an important cause contributing to these changes. Zoccali et al. correlated inflammatory markers interleukin 6 (IL6), C reactive protein (CRP), and endothelial adhesion molecules with FT3 in patients on hemodialysis. They postulated a decrease in FT3 as a manifestation of inflammation occurring in CKD patients which might be somewhat reversed once the inflammation is controlled. [15] Inflammatory cytokines such as tumor necrosis factor (TNF) α and IL6 have been found to have inverse relationship to T3. [15, 16] Another study evaluated the contribution of inflammation and thyroid function as risk factors for acute kidney injury (AKI). They evaluated if thyroid hormone levels and CRP had any influence on cystatin C, a renal biomarker. Although CRP was found to have association with AKI, predictive value was not established. Furthermore, they did not find predictive value of thyroid function tests for AKI in these patients. [17] Contrary to these findings, another study observed positive association of subclinical hypothyroidism with CKD in patients with type 2 diabetes mellitus concluding the possibility of thyroid dysfunction posing as a risk factor for CKD. [18] Association of low thyroid hormones with high levels of high-sensitivity CRP and IL6 may contribute to impaired cardiovascular function and overall survival, highlighting their clinical significance in chronic kidney disorders.
Nonthyroidal illnesses producing low thyroid hormones, FT3 in particular, have been recognized by many. This active form of thyroid hormone if reduced may contribute to decreasing protein loss and balancing energy homeostasis. Thyroid dysfunction in CKD involving alteration in thyroid hormone metabolism and peripheral deiodination has been evaluated. Defect in deiodinase enzyme activity peripherally converting T4 to T3 causes reduced levels of T3. [8] Inactivation of T4 and T3 by conversion to reverse T3 and T2, respectively, involves selenium-dependent iodothyronine deiodinase. Alteration in selenoprotein homeostasis in CKD patients affecting thyroid hormone profile has been studied by Reinhardt et al. [19] Selenoprotein P is the major selenium transport protein representing the selenium status in the body. They observed that in patients with chronic renal disease, selenoprotein P had negative correlation with T4 levels, both total and free hormones. However, they did not find association of selenoprotein P with T3 and thyrotropin. They did not find any association between thyroid hormone status and selenoprotein P concentration in patients on chronic hemodialysis.
A distinct aspect looking into the common autoimmune etiology in patients having autoimmune thyroid diseases and glomerulonephritis is under review. Membranous, membranoproliferative, and other forms of glomerulonephritis have been associated with autoimmune thyroid disorders. The pathophysiology involves megalin, a thyrotropin-dependent glycoprotein. [20] Its role in immunopathogenesis of glomerular injury and glomerular deposition of immune complexes is hypothesized. Iodine excretion is also impaired in CKD, leading to its excess with resultant reduced uptake secondary to Wolff-Chaikoff effect. [14] This iodine metabolism defect may also result in hypothyroidism. Furthermore, role of low T3 in renal transplant patients with pretransplantation thyroid hormone status contributing to the results of transplantation is also generating interest. [21] conclusIons Abnormal thyroid hormone profile in blood without any underlying disorder of thyroid gland can occur in chronic renal disorders, causing difficulty and errors in their interpretation. Our data highlight that CKD leads to significant lowering of free thyroid hormone levels, with reduction correlating with the severity of renal disease. This projects the importance of thyroid hormone estimation along with exercising adequate care in interpretation of their results in patients with CKDs. Further larger studies evaluating the clinical significance of thyroid hormones status in CKD patients would enhance our understanding in the subject.
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